Therapeutic Efficacy Of Cefodizime In Combination With Minocycline Against Systemic Infection Caused By Methicillin-Resistant Staphylococcus Aureus In Immunocompromised Tumour Bearing Mice

N/ACitations
Citations of this article
3Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The in vivo synergistic effect of cefodizime (CDZM) in combination with minocycline (MINO) against methicillin-resistant Staphylococcus aureus (MRSA) was investigated. A study of fractional effective dose (FED) index showed that either synergistic or additive effect was observed between CDZM and MINO. The postantibiotic effect (PAE) of MINO was not altered by the addition of CDZM. However, a strong synergistic bactericidal effect of CDZM and MINO against MRSA CT- 18 was observed for more than 14 hours in the presence of immunocompromised tumour bearing murine polymorphonuclear leukocytes (PMN). These results suggest that the strong therapeutic efficacy of CDZM in combination with MINO was caused by synergistic bactericidal effect of the 2 drugs in the presence of PMN. © 1993, Japan Antibiotics Research Association. All rights reserved.

Cite

CITATION STYLE

APA

Furukawa, T., Shimizu, C., Uji, T., Miyake, Y., Hyodo, A., & Deguchi, K. (1993). Therapeutic Efficacy Of Cefodizime In Combination With Minocycline Against Systemic Infection Caused By Methicillin-Resistant Staphylococcus Aureus In Immunocompromised Tumour Bearing Mice. Japanese Journal of Antibiotics, 46(4), 310–317. https://doi.org/10.11553/antibiotics1968b.46.310

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free